Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome.
BACKGROUND
Severe acute respiratory syndrome (SARS) is an emerging infectious disease, and indeed, the SARS epidemic in Taiwan from March to July 2003 had a great impact. This study depicts the clinical characteristics and short-term outcomes of patients with SARS treated at Taipei Veterans General Hospital; potential predictive factors for acute respiratory distress syndrome (ARDS) are also analyzed.


METHODS
This study retrospectively analyzed data for 67 SARS patients, who were grouped according to whether or not ARDS developed during the clinical course of SARS.


RESULTS
There were 32 males (mean age, 50.3 years; range, 20-75 years) and 35 females (mean age, 51.1 years; range, 23-86 years). Twenty-five patients (37.3%) were health care workers. At admission, 50 patients (74.6%) had abnormal chest radiographs, and all patients developed pulmonary infiltrates during the following week. During hospitalization, lymphopenia was found in 57 patients (85.1%); and elevated levels of lactate dehydrogenase (LDH; n = 55; 83.3%), C-reactive protein (n = 55; 83.3%), aminotransferases (n = 44; 65.7%), and creatine kinase (n = 14; 20.9%) were also noted. ARDS developed in 33 patients (49.3%), who were generally older than the patients in whom ARDS did not develop, male, non-health care workers, and who generally had dyspnea at the time of diagnosis, and a history of diabetes mellitus, hypertension or cerebrovascular accident. Patients with, versus those without, ARDS also tended to present with more severe lymphopenia and leukocytosis, and with higher levels of LDH and aspartate aminotransferase. The overall mortality rate was 31.3% (21/67), whereas the rate for patients who developed ARDS was 63.6% (21/33). Multivariate analyses showed that age greater than 65 years (odds ratio, OR, 10.6; 95% confidence interval, CI, 2.1-54.1), pre-existing diabetes mellitus (OR, 13.7; 95% CI, 1.3-146.9), and elevated levels of LDH (OR, 8.4; 95% CI, 1.9-36.9) at admission, were independent predictors of ARDS.


CONCLUSIONS
The clinical manifestations of SARS showed high variability, and were related to the underlying health status of individual patients. Importantly, the development of ARDS was associated with significant mortality, despite aggressive therapy.
Chen
Cheng-Yu
CY
Chest Department, Taipei Veterans General Hospital, Taiwan, ROC.
Lee
Chen-Hsen
CH
Liu
Cheng-Yi
CY
Wang
Jia-Horng
JH
Wang
Lee-Min
LM
Perng
Reury-Perng
RP
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006761:Hospitals; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012128:Respiratory Distress Syndrome / Q000209:etiology*; D012189:Retrospective Studies; D012307:Risk Factors; D045169:Severe Acute Respiratory Syndrome / Q000150:complications* / Q000473:pathology / Q000628:therapy; D013624:Taiwan
N Engl J Med. 2003 May 15;348(20):1977-85
12671062
Emerg Infect Dis. 2003 Jun;9(6):718-20
12781013
N Engl J Med. 2003 May 15;348(20):1986-94
12682352
Radiology. 2003 Aug;228(2):395-400
12738877
Clin Infect Dis. 2000 Jul;31(1):96-100
10913403
J Infect Dis. 2002 May 1;185(9):1338-41
12001053
N Engl J Med. 2003 May 15;348(20):1995-2005
12671061
BMJ. 2003 Jun 21;326(7403):1354-8
12816820
MMWR Morb Mortal Wkly Rep. 2003 May 23;52(20):461-6
12807078
Radiology. 2003 Aug;228(2):401-6
12759474
Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818-24
7509706
J Chin Med Assoc. 2003 Jun;66(6):328-38
12889501
Clin Chem. 2003 Jun;49(6 Pt 1):953-5
12765993
Lancet. 2003 Apr 19;361(9366):1319-25
12711465
N Engl J Med. 2003 May 15;348(20):1953-66
12690092
JAMA. 2003 Jun 4;289(21):2801-9
12734147
N Engl J Med. 2003 May 15;348(20):1967-76
12690091
N Engl J Med. 2003 May 15;348(20):e6-7
12671060